Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
24,903,753
-
Share change
-
-543,253
-
Total reported value
-
$2,842,785,020
-
Put/Call ratio
-
188%
-
Price per share
-
$114.15
-
Number of holders
-
298
-
Value change
-
-$64,705,528
-
Number of buys
-
117
-
Number of sells
-
184
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2019
As of 30 Jun 2019,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
298 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,903,753 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, CARDINAL CAPITAL MANAGEMENT LLC /CT, Conestoga Capital Advisors, LLC, VICTORY CAPITAL MANAGEMENT INC, and MACQUARIE GROUP LTD.
This page lists
298
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.